Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Amgen
Hoffmann-La Roche
Advaxis, Inc.
Pfizer
Ludwig Institute for Cancer Research
Hoffmann-La Roche
PharmaMar
GlaxoSmithKline
GlaxoSmithKline
Takeda
Pfizer